iBio (IBIO) Change in Net Loans (2024 - 2025)

iBio's (IBIO) quarterly Change in Net Loans came in at $46000.0 in Q2 2025, up 4700.0% on a QoQ basis from -$1000.0 in Q4 2024.

iBio (IBIO) Change in Net Loans (2024 - 2025) Analysis & Trends

iBio (IBIO) has 2 years of Change in Net Loans data on file, last reported at $46000.0 in Q2 2025.

On a quarterly basis, Change in Net Loans changed N/A year-over-year to $46000.0 in Q2 2025; TTM through Jun 2025 was $758000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $758000.0, changed N/A from the prior year.
Change in Net Loans for Q2 2025 stood at $46000.0, up from -$1000.0 in the prior quarter.
Over the last five years, Change in Net Loans for IBIO reached as high as $713000.0 in Q3 2024 and fell as low as -$1000.0 in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Net Loans (Qtr)
1	Oculis Holding AG	66,621.14 Bn	66,620.85 Bn	-	-
2	Nanobiotix	1,915.18 Bn	1,915.11 Bn	-	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	-
4	BeOne Medicines	471.27 Bn	466.48 Bn	1.35 Bn	-
5	Vertex Pharmaceuticals	121.81 Bn	114.57 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	69.58 Bn	60.82 Bn	3.31 Bn	-
7	Belite Bio	62.72 Bn	62.72 Bn	-	-
8	Argenx Se	55.51 Bn	50.33 Bn	1.41 Bn	-
9	Revolution Medicines	37.35 Bn	37.35 Bn	-	-
10	iBio	172.22 Mn	172.22 Mn	-	-

Download Data